This Week’s Life Science Headlines December 1, 2013 / Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements / Life Science Matters Litigation Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required) Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required) Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required) OxyElite Pro Class Action Filed Over False Advertising First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014 J&J Takes Innovative, If Pricey, Route to Ending Hip Suits (subscription required) Regulatory Avandia REMS Program Modified by FDA to Loosen Restrictions DNA Tests on Notice as FDA Warns Wife of Google’s Brin (subscription required) FDA Scrutiny Looms for Unapproved Research Tests (subscription required) FDA Loosens Restrictions on GSK’s Avandia (subscription required) FDA Calls Out Amgen Over Misleading Anemia Drug Claims (subscription required) Rips “Troubling” Drug Promo in Repeat Warning Letter (subscription required) Recalls Abbott Issues Voluntary Recall of Certain FreeStyle® and FreeStyle Lite® Glucose Test Strips Viscocel Recall Issued for Eye Solution Due to Lack of FDA Approval For a look at last week’s important life science headlines, click here. Life Science Matters
This Week’s Life Science Headlines
Litigation
Regulatory
Recalls
For a look at last week’s important life science headlines, click here.
Life Science Matters
Next ArticleThis Week's Life Science Headlines